Stata DX
Cambridge · Founded 2022
About Stata DX
Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies. The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about the composition of a system in real-time. Stata DX was established in Cambridge, Massachusetts.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2024)
- Website: https://www.statadx.com
Industries & Categories
Biotechnology, Chemical Engineering, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/stata-dx-15518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.